The Controversy over SUPPORT Continues and the Hyperbole Increases

Two articles in this issue of the Hastings Center Report address the continuing controversy over the Surfactant, Positive Pressure, and Oxygenation Randomized Trial (SUPPORT). This controversy is part of a larger discussion about the appropriate regulatory framework for protecting human research par...

Full description

Saved in:
Bibliographic Details
Published inThe Hastings Center report Vol. 45; no. 1; pp. 42 - 44
Main Author Fleischman, Alan R.
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.01.2015
The Hastings Center
Subjects
Bioethics
Brain Injuries - prevention & control
Clinical trials
Comparative analysis
Comparative Effectiveness Research - ethics
Effectiveness
Humans
Infant, Premature
Intensive Care, Neonatal - ethics
Medical ethics
Medical treatment
Other Voices
Oximetry
Oxygen - blood
Oxygen therapy
Parental Consent - ethics
Positive-Pressure Respiration
Premature birth
Research Design
Retinopathy of Prematurity - prevention & control
Risk Adjustment
Standard of Care
Truth Disclosure - ethics
Online AccessGet full text

Cover

More Information
Summary:Two articles in this issue of the Hastings Center Report address the continuing controversy over the Surfactant, Positive Pressure, and Oxygenation Randomized Trial (SUPPORT). This controversy is part of a larger discussion about the appropriate regulatory framework for protecting human research participants in comparative effectiveness research (CER), a group of studies that aims to compare two “usual” or “standard” treatments in order to provide evidence of which treatment is most effective.
Bibliography:ArticleID:HAST416
istex:511115BBCB695F1AB844631B631E8569DFAE806D
ark:/67375/WNG-X09J12VD-D
45, no. 1 (2015): 42–44. doi: 10.1002/hast.416
Alan R. Fleischman, “The Controversy over SUPPORT Continues and Hyperbole Increases,”
Hastings Center Report
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Commentary-1
ISSN:0093-0334
1552-146X
DOI:10.1002/hast.416